The current rules: People who initially received Pfizer or Moderna vaccinations are eligible for a booster six months later if they’re 65 or older, or are at high risk of COVID-19.
Taiwan had been unable to buy the vaccine itself directly from BioNTech, the German company that had partnered with U.S.-based Pfizer to develop the mRNA vaccine.
Some of these events have led to restricted use of the Oxford-AstraZeneca vaccine, known as Covishield in India, in a number of countries.
It has submitted more data to US drug regulator from the late-stage clinical trials and ongoing vaccinations
The company has said the windfall from its mRNA-based coronavirus vaccine will help it to develop drugs against cancer and other diseases.
The Germany-based company aims to begin clinical trials for a 'safe and highly effective malaria vaccine' by the end of next year.
The project will take time to get off the ground however, with the first African-finished vaccines not expected before 2022.
People are less likely to develop antibody levels against the B.1.617.2 variant as high as those seen against the previously dominant B.1.1.7 variant.
The mixing of vaccines comes as the Mideast island nation struggles through its worst wave of the virus despite being one of the top countries in the world in per-capita inoculations.
The other day, I was chatting with a friend who lives in the US. She was crowing about having gone for her Covid vaccination. Pfizer, she informed me.
Ugur Sahin, the chief executive of BioNTech, rejected the US-backed proposal to temporarily lift some intellectual property rights for vaccines in order to boost global supply during the pandemic.
Shanghai Fosun Pharmaceutical Group Co. said in a stock filing on Sunday night that the companies will invest up to $100 million each to set up the venture.
Delivery of doses is set to begin this month to give Olympic delegations time to be fully vaccinated with a second shot before arriving in Tokyo for the games, which open on July 23.
The two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective.
The downside is that the doses must be kept at ultralow temperatures, though Pfizer has managed to demonstrate that its vaccine can be kept up to two weeks at less intense cold.